Transcriptional Regulation of HMG-CoA Synthase and HMG-CoA Reductase Genes by Human ACBP

The acyl-CoA binding protein (ACBP) is an ubiquitary expressed multi-functional protein which regulates basic cellular functions such as fatty acid and steroid metabolism. Since ACBP is described to interact with the transcription factor hepatocyte nuclear factor 4 alpha (HNF-4α), we investigated the role of human ACBP on transcriptional regulation of the putative HNF-4α target gene HMG-CoA synthase 1 (HMGCS1). As shown by promoter-reporter assays ACBP represses the HNF-4α-induced activity of a 617bp HMGCS1 promoter fragment by approximately 80% in HepG2 cells as well as in non-endodermal HeLa cells devoid of HNF-4α. Interestingly, reporter assays without co-transfection of HNF-4α revealed that ACBP reduces the activity of the HMGCS1 promoter by about 60 to 80% in both cell lines. Activities of 417bp and 317bp HMGCS1 promoter fragments were 2.5 to 4 fold decreased by ACBP. Concordantly, the levels of HMGCS1-mRNA and -protein were diminished to 60% and 70% in ACBP-expressing HeLa cells, respectively. Additionally, ACBP reduces the promoter activity and the mRNA levels of the cholesterogenic HMG-CoA reductase (HMGCR). In conclusion, we provide evidence that ACBP is a transcriptional regulator of the HMGCS1 and HMGCR genes encoding rate-limiting enzymes of cholesterol synthesis pathway.

[1]  Manoj K Mishra,et al.  Transcriptional downregulation of sterol metabolism genes in murine liver exposed to acute hypobaric hypoxia. , 2007, Biochemical and biophysical research communications.

[2]  J. Gogusev,et al.  Modulation of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, interleukin-8, and granulocyte/macrophage colony-stimulating factor expression in human monocytes by an endogenous anxiogenic benzodiazepine ligand, triakontatetraneuropeptide: evidence for a role of prostaglandins. , 1993, Molecular pharmacology.

[3]  J. Inoue,et al.  Multiple DNA elements for sterol regulatory element-binding protein and NF-Y are responsible for sterol-regulated transcription of the genes for human 3-hydroxy-3-methylglutaryl coenzyme A synthase and squalene synthase. , 1998, Journal of biochemistry.

[4]  V. Papadopoulos,et al.  Peripheral-type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis , 2003, Steroids.

[5]  C. DiRusso,et al.  Characterization of FadR, a global transcriptional regulator of fatty acid metabolism in Escherichia coli. Interaction with the fadB promoter is prevented by long chain fatty acyl coenzyme A. , 1992, The Journal of biological chemistry.

[6]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[7]  M. Butchbach,et al.  Association of Excitatory Amino Acid Transporters, Especially EAAT2, with Cholesterol-rich Lipid Raft Microdomains , 2004, Journal of Biological Chemistry.

[8]  S. Hwang,et al.  Regulatory Elements That Control Transcription Activation and Unsaturated Fatty Acid-mediated Repression of the Saccharomyces cerevisiae OLE1 Gene (*) , 1996, The Journal of Biological Chemistry.

[9]  B. Kragelund,et al.  Acyl-coenzyme A binding protein (ACBP). , 1999, Biochimica et biophysica acta.

[10]  F. Schroeder,et al.  Membrane charge and curvature determine interaction with acyl-CoA binding protein (ACBP) and fatty acyl-CoA targeting. , 2002, Biochemistry.

[11]  F. Spener,et al.  A novel acyl-CoA-binding protein from bovine liver. Effect on fatty acid synthesis. , 1987, The Biochemical journal.

[12]  K. Yanagibashi,et al.  The regulation of intracellular transport of cholesterol in bovine adrenal cells: purification of a novel protein. , 1988, Endocrinology.

[13]  M. Nakanishi,et al.  Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme. , 1988, The Journal of biological chemistry.

[14]  B. Descamps-Latscha,et al.  Endogenous anxiogenic peptide, ODN-diazepam-binding inhibitor, and benzodiazepines enhance the production of interleukin-1 and tumor necrosis factor by human monocytes. , 1991, Lymphokine and cytokine research.

[15]  B. Persson,et al.  Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release. , 1988, European journal of biochemistry.

[16]  P. Højrup,et al.  Acyl-CoA-binding protein in the rat. Purification, binding characteristics, tissue concentrations and amino acid sequence. , 1989, The Biochemical journal.

[17]  J. Inoue,et al.  Sterol Regulatory Element-binding Protein-2 Interacts with Hepatocyte Nuclear Factor-4 to Enhance Sterol Isomerase Gene Expression in Hepatocytes* , 2003, Journal of Biological Chemistry.

[18]  V. Papadopoulos,et al.  Diazepam binding inhibitor is a paracrine/autocrine regulator of Leydig cell proliferation and steroidogenesis: action via peripheral-type benzodiazepine receptor and independent mechanisms. , 1993, Endocrinology.

[19]  K. Kristiansen,et al.  Effect of heterologous expression of acyl-CoA-binding protein on acyl-CoA level and composition in yeast. , 1993, The Biochemical journal.

[20]  K. Dooley,et al.  Sterol Regulation of 3-Hydroxy-3-Methylglutaryl-coenzyme A Synthase Gene through a Direct Interaction Between Sterol Regulatory Element Binding Protein and the Trimeric CCAAT-binding Factor/Nuclear Factor Y* , 1998, The Journal of Biological Chemistry.

[21]  L. Freedman,et al.  Ligand modulates the conversion of DNA-bound vitamin D3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers , 1994, Molecular and cellular biology.

[22]  Anca D Petrescu,et al.  Physical and functional interaction of Acyl-CoA-binding protein with hepatocyte nuclear factor-4 alpha. , 2003, The Journal of biological chemistry.

[23]  N. Færgeman,et al.  Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling. , 1997, The Biochemical journal.

[24]  L. Alhonen,et al.  Downregulation of PPARs and SREBP by acyl-CoA-binding protein overexpression in transgenic rats , 2008, Pflügers Archiv - European Journal of Physiology.

[25]  B. Atshaves,et al.  Acyl-coenzyme A binding protein expression alters liver fatty acyl-coenzyme A metabolism. , 2005, Biochemistry.

[26]  K. Herzig,et al.  Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  P. D. Stefanis,et al.  Modulation of insulin secretion by diazepam binding inhibitor and its processing products , 1991, Neuropharmacology.

[28]  V. Mutt,et al.  Isolation of three antibacterial peptides from pig intestine: gastric inhibitory polypeptide (7-42), diazepam-binding inhibitor (32-86) and a novel factor, peptide 3910. , 1993, European journal of biochemistry.

[29]  K. Kristiansen,et al.  Yeast acyl-CoA-binding protein: acyl-CoA-binding affinity and effect on intracellular acyl-CoA pool size. , 1994, The Biochemical journal.

[30]  K. Kristiansen,et al.  Acyl-CoA-binding protein (ACBP) can mediate intermembrane acyl-CoA transport and donate acyl-CoA for beta-oxidation and glycerolipid synthesis. , 1994, The Biochemical journal.

[31]  S. Feddersen,et al.  Transcriptional regulation of phospholipid biosynthesis is linked to fatty acid metabolism by an acyl-CoA-binding-protein-dependent mechanism in Saccharomyces cerevisiae. , 2007, The Biochemical journal.

[32]  A. Guidotti,et al.  Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[33]  K. Kristiansen,et al.  Acyl-CoA Esters Antagonize the Effects of Ligands on Peroxisome Proliferator-activated Receptor α Conformation, DNA Binding, and Interaction with Co-factors* , 2001, The Journal of Biological Chemistry.

[34]  J. Bar-Tana,et al.  Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4α , 1998, Nature.

[35]  J. Knudsen,et al.  Interaction of acyl-CoA binding protein (ACBP) on processes for which acyl-CoA is a substrate, product or inhibitor. , 1993, The Biochemical journal.

[36]  F. Schroeder,et al.  Structure and function of normal and transformed murine acyl-CoA binding proteins. , 1998, Archives of biochemistry and biophysics.

[37]  J. Bar-Tana,et al.  Physical and Functional Interaction of Acyl-CoA-binding Protein with Hepatocyte Nuclear Factor-4α* , 2003, Journal of Biological Chemistry.

[38]  V. Papadopoulos,et al.  Role of the peripheral-type benzodiazepine receptor and the polypeptide diazepam binding inhibitor in steroidogenesis , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[39]  M. Brown,et al.  Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. , 1980, Journal of lipid research.

[40]  V. Papadopoulos,et al.  Inhibition of hormone-stimulated steroidogenesis in cultured Leydig tumor cells by a cholesterol-linked phosphorothioate oligodeoxynucleotide antisense to diazepam-binding inhibitor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. Parthasarathy,et al.  Evidence that acyl coenzyme A synthetase activity is required for repression of yeast acetyl coenzyme A carboxylase by exogenous fatty acids. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Knudsen,et al.  The interaction of acyl-CoA with acyl-CoA binding protein and carnitine palmitoyltransferase I. , 2001, The international journal of biochemistry & cell biology.

[43]  F. Döring,et al.  The human intestinal fatty acid binding protein (hFABP2) gene is regulated by HNF-4alpha. , 2007, Biochemical and biophysical research communications.

[44]  Jerrold M. Ward,et al.  Hepatocyte Nuclear Factor 4α (Nuclear Receptor 2A1) Is Essential for Maintenance of Hepatic Gene Expression and Lipid Homeostasis , 2001, Molecular and Cellular Biology.

[45]  T D Lee,et al.  Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[46]  D. Wilton,et al.  Microsomal fatty acyl-CoA transacylation and hydrolysis: fatty acyl-CoA species dependent modulation by liver fatty acyl-CoA binding proteins. , 2000, Biochimica et biophysica acta.

[47]  J. Olsen,et al.  Differentiation-dependent activation of the human intestinal alkaline phosphatase promoter by HNF-4 in intestinal cells. , 2005, American journal of physiology. Gastrointestinal and liver physiology.